Spinal cord stimulation for treating neuropathic pain after chemotherapy / radiotherapy; a pilot study
Recruiting
- Conditions
- neuropathic pain caused by chemotherapy / radiotherapy10034606
- Registration Number
- NL-OMON47554
- Lead Sponsor
- Medisch Spectrum Twente
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 11
Inclusion Criteria
- Peripheral neuropathic pain in lower extremities that exists for more than 6
months and is due to chemotherapy / radiotherapy.
- Patient cannot be treated further otherwise according to patients* medical
specialist.
- The pain-sensation on a visual analogue scale is 5 or more.
Exclusion Criteria
- Psychological problems that requires treatment.
- Insufficient cooperation by patient (motivation, insight or communication).
- Coagulation irregularities/ Anti-coagulants.
- Life expectancy less than 1 year.
- Local infection at the site of the incision
- Implanted pacemaker, ICD or other neuromodulation system
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome measure is the change in neuropathic pain as measured by VAS<br /><br>score after 6 months of SCS. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary objectives are an evaluation of the efficacy of SCS treatment in<br /><br>patients with post cancer neuropathic pain as measured by change in pain<br /><br>intensity at all visits, and an evaluation of following health outcome<br /><br>measures: McGill Pain Questionnaire, EuroQoL 5D, HADS, patient's satisfaction,<br /><br>changes in pain medication, changes in EEG features.</p><br>